If you made any changes in Pure these will be visible here soon.

Personal profile

External positions

Cardiologist, Thorax Centrum Twente

1 Jan 2017 → …

Fingerprint Dive into the research topics where Gian Paolo Zocca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Drug-Eluting Stents Medicine & Life Sciences
clopidogrel Medicine & Life Sciences
Stents Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Prediabetic State Medicine & Life Sciences
Polymers Medicine & Life Sciences
Acute Coronary Syndrome Medicine & Life Sciences
Percutaneous Coronary Intervention Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

  • 16 Citations
  • 2 h-Index
  • 8 Article
1 Citation (Scopus)

Outcomes in Patients Treated with Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial

Buiten, R. A., Ploumen, E. H., Zocca, P., Doggen, C. J. M., Van Der Heijden, L. C., Kok, M. M., Danse, P. W., Schotborgh, C. E., Scholte, M., De Man, F. H. A. F., Linssen, G. C. M. & Von Birgelen, C., 21 May 2019, In : JAMA Cardiology.

Research output: Contribution to journalArticleAcademicpeer-review

Drug-Eluting Stents
Stents
Coronary Vessels
Sirolimus
Polymers
28 Downloads (Pure)

High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial

Zocca, P., Kok, M. M., van der Heijden, L. C., Danse, P. W., Schotborgh, C. E., Scholte, M., Hartmann, M., Linssen, G. C. M., Doggen, C. J. M. & von Birgelen, C., 1 Dec 2018, In : Cardiovascular Drugs and Therapy. 32, 6, p. 567–576 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
Drug-Eluting Stents
Polymers
Hemorrhage
Safety
Arteritis
4 Citations (Scopus)
10 Downloads (Pure)

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT

Zocca, P., Kok, M. M., van der Heijden, L. C., van Houwelingen, K. G., Hartmann, M., de Man, F. H. A. F., Stoel, M. G., Louwerenburg, J. H. W., Knottnerus, I. L., Linssen, G. C. M., Doggen, C. J. M. & von Birgelen, C., 1 Oct 2018, In : International journal of cardiology. 268, p. 11-17 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
clopidogrel
Drug-Eluting Stents
Acute Coronary Syndrome
Hemorrhage
Ticagrelor
11 Citations (Scopus)

Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial

von Birgelen, C., Zocca, P., Buiten, R. A., Jessurun, G. A. J., Schotborgh, C. E., Roguin, A., Danse, P. W., Benit, E., Aminian, A., van Houwelingen, K. G., Anthonio, R. L., Stoel, M. G., Somi, S., Hartmann, M., Linssen, G. C. M., Doggen, C. J. M. & Kok, M. M., 6 Oct 2018, In : Lancet. 392, 10154, p. 1235-1245 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Four-year clinical outcome following randomised use of zotarolimus-eluting stents versus everolimus-eluting stents in all-comers: Insights from the DUTCH PEERS trial

Lowik, M., Van Der Heijden, L. C., Kok, M. M., Zocca, P., Danse, P. W., Jessurun, G. A. J., Hautvast, R. W. M., Hartmann, M., Stoel, M. G., Linssen, G. C. M., Doggen, C. J. M. & Von Birgelen, C., 29 Aug 2017, In : European heart journal. 38, Supplement 1, p. 620 1 p.

Research output: Contribution to journalArticleAcademic

Stents
Chromium
zotarolimus
Everolimus
Incidence

Activities 2018 2018

  • 1 Editorial work

EuroIntervention (Journal)

Gian Paolo Zocca (Reviewer)
1 May 2018 → …

Activity: Publication peer-review and editorial workEditorial work